The ability of calcium to activate the androgen receptor and the association of calcium intake and calcium channels with prostate cancer suggest that new therapies for the treatment of prostate cancer, which include drugs that target specific calcium channels or transporters, should be further investigated. This evidence concerns the gene AR and prostate cancer.